Royal Bank of Canada’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding LHDX
EV
RA
CS
Royal Bank of Canada's LHDX Position: Q1 2023 in Review
Royal Bank of Canada sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 11,660 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $100K in Q4 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.
- Royal Bank of Canada reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 11,660 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1K.
- Royal Bank of Canada first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
- Royal Bank of Canada's Lucira Health, Inc. Common Stock position peaked at $100K in Q4 2021.
- 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.